Seunghwan Kim, CEO of Amorepacific: "Dermabeauty, Clinical Skincare, and Haircare to Lead New Growth... 15 Trillion Won Sales Target by 2035"

Global Expansion for EstrA and Illiyoon
IOPE Targets Europe After Entry Into US Sephora
Ryo, Mise-en-Scène, and Other Haircare Brands Advance Overseas
15 Trillion Won Sales Target by 2035

Amorepacific is positioning dermabeauty, clinical skincare, and haircare as new pillars of global growth. The company’s strategy is to accelerate toward its 2035 goal of reaching 15 trillion won in group sales by expanding the overseas operations of its core brands while cultivating categories with strong growth potential.

Amorepacific announced on September 14 that it held its "2026 Investor Day" at its headquarters in Yongsan, Seoul, on September 11, unveiling its mid- to long-term management goals and business-specific global growth strategies to domestic and international institutional investors and analysts.

In dermabeauty, the company presented a goal of reaching 1 trillion won in sales by BY30 (July 2029–June 2030), centering on the EstrA and Illiyoon brands. EstrA, led by its flagship product “Atobarrier365,” has entered 36 countries over the past three years, with global sales more than quadrupling last year. The company plans to expand into nine additional countries by the first half of next year.

Illiyoon aims to grow its “Ato Cream” into its core global product. The company will expand primarily through digital channels such as Amazon in the United States and TikTok Shop, and plans to broaden connections with local consumers by leveraging social media.

The clinical skincare brand IOPE will also further expand its overseas business. Leveraging its expertise connected to research on dermatological procedures and high-efficacy ingredients such as PDRN and retinol, IOPE, having already entered Sephora in the United States, plans to enter the European market by the first half of next year. The target is to build IOPE into a brand with annual sales of 500 billion won by 2035.

Haircare, too, will see its global business expanded based on a portfolio of brands including Ryo, Mise-en-Scène, LABO-H, Longtake, Aeyoonche, and Amos Professional. The company aims for 1 trillion won in sales and over 60% global sales composition by BY30, and will strengthen its premium haircare and scalp care offerings in key markets such as the United States, China, Japan, and Brazil. Mise-en-Scène’s “Perfect Serum” is already showing strong results, ranking first in the hair styling oil category on Amazon in the United States.

Amorepacific plans to scale up its proven growth models for each brand into the overseas market, leveraging digital channels such as social media and e-commerce. The company will refine its marketing and investment strategies by utilizing consumer data and insights from each market and channel, aiming to enhance both growth and profitability.

Based on these initiatives, Amorepacific also set a target of achieving 10% sales growth and an operating margin of over 11% by BY27 (July 2026–June 2027). The company intends to expand its global business with a focus on core markets such as the Americas, Europe, and Japan, while strengthening the competitiveness of its growth categories.

Seunghwan Kim, CEO of Amorepacific, stated, "We will accelerate the growth of our core brands and foster dermabeauty, clinical skincare, and haircare as new pillars of global growth. We will further reinforce our fundamental competitive strengths—brand value, technological prowess, and quality—while responding agilely to changes in customers and markets driven by social media, e-commerce, and AI."

This content was produced with the assistance of AI translation services.